TR200401333T4 - (S)-2 Etoksi -3-4- (2-4-Metansulfoniloksifenil Etoksi) Fenil] Propanoik Asidin Kristal Formu - Google Patents

(S)-2 Etoksi -3-4- (2-4-Metansulfoniloksifenil Etoksi) Fenil] Propanoik Asidin Kristal Formu

Info

Publication number
TR200401333T4
TR200401333T4 TR2004/01333T TR200401333T TR200401333T4 TR 200401333 T4 TR200401333 T4 TR 200401333T4 TR 2004/01333 T TR2004/01333 T TR 2004/01333T TR 200401333 T TR200401333 T TR 200401333T TR 200401333 T4 TR200401333 T4 TR 200401333T4
Authority
TR
Turkey
Prior art keywords
ethoxy
crystalline form
methanesulfonyloxyphenyl
phenyl
propanoic acid
Prior art date
Application number
TR2004/01333T
Other languages
English (en)
Inventor
Boije Maria
Horvath Karol
Inghardt Tord
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904416A external-priority patent/SE9904416D0/xx
Priority claimed from SE0001187A external-priority patent/SE0001187D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TR200401333T4 publication Critical patent/TR200401333T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut icat, (S) -2-etoksi -3- [4-(2-{4-metansulfoniloksifenil} etoksi) fenil] propanoik asit bileseninin yeni bir kristal formu ile ilgili olup, formül (I) ile veya farmasötik olarak kabul gören tuzlari ve bunun solvatlari ile gösterilir. Icat ayrica, bir veya daha fazla metabolik hastalik durumunun, bilhassa Insülin Direnç Sendorumunun tedavi edilmesinde kullanilmakta olup, bilesenin kristal formunun veya farmasötik olarak kabul gören tuzlari veya bunlarin solvatlari, belirtilen sartlarin birinde veya daha fazlasinda kullanilmak üzere ilaç imalatinda kullanilir. Icat ayrica, bilesenin kristal formunun veya farmasötik olarak kabul gören tuzlari veya bunlarin solvatlarinin imalat süreçlerinde de kullanilir.
TR2004/01333T 1999-12-03 2000-11-29 (S)-2 Etoksi -3-4- (2-4-Metansulfoniloksifenil Etoksi) Fenil] Propanoik Asidin Kristal Formu TR200401333T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9904416A SE9904416D0 (sv) 1999-12-03 1999-12-03 Crystalline form
SE0001187A SE0001187D0 (sv) 2000-04-03 2000-04-03 Crystalline form

Publications (1)

Publication Number Publication Date
TR200401333T4 true TR200401333T4 (tr) 2004-08-23

Family

ID=26655058

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/01333T TR200401333T4 (tr) 1999-12-03 2000-11-29 (S)-2 Etoksi -3-4- (2-4-Metansulfoniloksifenil Etoksi) Fenil] Propanoik Asidin Kristal Formu

Country Status (29)

Country Link
US (1) US6531622B1 (tr)
EP (1) EP1237855B1 (tr)
JP (1) JP2003515582A (tr)
KR (1) KR20030029040A (tr)
CN (1) CN1198799C (tr)
AR (1) AR029412A1 (tr)
AT (1) ATE261431T1 (tr)
AU (1) AU773777B2 (tr)
BR (1) BR0016131A (tr)
CA (1) CA2392038A1 (tr)
CO (1) CO5271735A1 (tr)
CZ (1) CZ20021902A3 (tr)
DE (1) DE60008921T2 (tr)
DK (1) DK1237855T3 (tr)
EE (1) EE200200278A (tr)
ES (1) ES2215769T3 (tr)
HU (1) HUP0203444A3 (tr)
IL (1) IL149577A0 (tr)
IS (1) IS6400A (tr)
MX (1) MXPA02005327A (tr)
MY (1) MY135954A (tr)
NO (1) NO20022598L (tr)
NZ (1) NZ518925A (tr)
PL (1) PL357118A1 (tr)
PT (1) PT1237855E (tr)
RU (1) RU2268880C2 (tr)
SK (1) SK7652002A3 (tr)
TR (1) TR200401333T4 (tr)
WO (1) WO2001040171A1 (tr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749505B2 (en) 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
AU752059B2 (en) 1997-10-27 2002-09-05 Dr. Reddy's Laboratories Limited Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
CN1280574A (zh) 1997-10-27 2001-01-17 雷迪研究基金会 新的杂环化合物及其在医药中的应用、它们的制备方法和含有它们的药物组合物
US6369067B1 (en) 1997-10-27 2002-04-09 Dr. Reddy's Research Foundation Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
US6440961B1 (en) 1997-10-27 2002-08-27 Dr. Reddy's Research Foundation Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
AU763087B2 (en) 1998-10-29 2003-07-10 Dr. Reddy's Laboratories Limited An improved process for the preparation of new antidiabetic agents
US6531596B1 (en) 1998-10-29 2003-03-11 Dr. Reddy's Laboratories Ltd. Process for the preparation of new antidiabetic agents
US7084177B2 (en) * 1999-12-03 2006-08-01 Astrazeneca Ab Comminuted form of(S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl] propanoic acid
US6897199B2 (en) 2001-02-05 2005-05-24 Dr. Reddy's Laboratories Ltd. Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds
US7148246B2 (en) 2003-02-27 2006-12-12 Sanofi-Aventis Deutschland Gmbh Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10308353A1 (de) 2003-02-27 2004-12-02 Aventis Pharma Deutschland Gmbh Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308351A1 (de) 2003-02-27 2004-11-25 Aventis Pharma Deutschland Gmbh 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10308352A1 (de) 2003-02-27 2004-09-09 Aventis Pharma Deutschland Gmbh Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
EP1586573B1 (en) 2004-04-01 2007-02-07 Sanofi-Aventis Deutschland GmbH Oxadiazolones, processes for their preparation and their use as pharmaceuticals
DE102004035034A1 (de) * 2004-07-20 2006-02-16 Degussa Ag Racematspaltung von p-Hydroxyphenyl-2-alkoxy-propionsäuren
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
MA26634A1 (fr) * 1998-06-04 2004-12-20 Astra Ab Nouveaux derives de l'acide 3-aryl propionique et analogues

Also Published As

Publication number Publication date
EE200200278A (et) 2003-06-16
ATE261431T1 (de) 2004-03-15
AU773777B2 (en) 2004-06-03
CN1409701A (zh) 2003-04-09
CN1198799C (zh) 2005-04-27
ES2215769T3 (es) 2004-10-16
NO20022598D0 (no) 2002-05-31
RU2002113450A (ru) 2004-01-10
NO20022598L (no) 2002-05-31
DK1237855T3 (da) 2004-06-14
BR0016131A (pt) 2002-08-20
KR20030029040A (ko) 2003-04-11
MXPA02005327A (es) 2002-12-06
PL357118A1 (en) 2004-07-12
EP1237855A1 (en) 2002-09-11
IS6400A (is) 2002-05-28
PT1237855E (pt) 2004-06-30
IL149577A0 (en) 2002-11-10
CA2392038A1 (en) 2001-06-07
CO5271735A1 (es) 2003-04-30
CZ20021902A3 (cs) 2002-11-13
US6531622B1 (en) 2003-03-11
HUP0203444A3 (en) 2003-05-28
HUP0203444A2 (hu) 2003-02-28
DE60008921T2 (de) 2005-01-20
RU2268880C2 (ru) 2006-01-27
JP2003515582A (ja) 2003-05-07
EP1237855B1 (en) 2004-03-10
SK7652002A3 (en) 2002-11-06
HK1048980A1 (en) 2003-04-25
NZ518925A (en) 2004-06-25
AR029412A1 (es) 2003-06-25
AU2035001A (en) 2001-06-12
WO2001040171A1 (en) 2001-06-07
DE60008921D1 (en) 2004-04-15
MY135954A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
TR200401333T4 (tr) (S)-2 Etoksi -3-4- (2-4-Metansulfoniloksifenil Etoksi) Fenil] Propanoik Asidin Kristal Formu
TR200003543T2 (tr) Yeni 3-aril-2-hidroksipropiyonik asit türevi III.
MY128664A (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
IL139636A (en) (s)-2-ethoxy-3-[4-(2{4-methanesulfonyloxyphenyl} ethoxy) phenyl] propanoic acid, process for its preparation, pharmaceutical composition containing it and use thereof in the manufacture of medicament for the prophylaxis or treatment of clinical conditions associated with insulin resistance
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
SE0104334D0 (sv) Therapeutic agents
TR200003333T2 (tr) Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler
TR200200649T2 (tr) Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri
WO2005016261A3 (en) Aripiprazole and haloperidol pamoate salts
ES2173499T3 (es) Sales de adicion de acidos de compuesto de piperidina opticamente activo y procedimiento para su preparacion.
JP2002513793A5 (tr)
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
TR200200076T2 (tr) Oral yoldan aktif androjenler
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
KR890006621A (ko) 항불안제
ATE444961T1 (de) Verbindungen vom hydrazidtyp und deren verwendung in pharmazeutischen zusammensetzungen zur behandlung von herzkreislauferkrankungen
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
RU2004126861A (ru) Производные пиридинамидов в качестве ингибиторов моноаминоксидазы (мао-в)
SE9904412D0 (sv) Comminuted form
AR026704A1 (es) Forma cristalina
EP1435962A4 (en) TREATMENT OF DIABETES TYPE I
CA2489834A1 (en) Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
JP2006516971A5 (tr)
NO20053876D0 (no) Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav
SE9904416D0 (sv) Crystalline form